Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,678 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monocyte Chemoattractant Protein-1 (MCP-1) as a Potential Therapeutic Target and a Noninvasive Biomarker of Liver Fibrosis Associated With Transient Myeloproliferative Disorder in Down Syndrome.
Kobayashi K, Yoshioka T, Miyauchi J, Nakazawa A, Yamazaki S, Ono H, Tatsuno M, Iijima K, Takahashi C, Okada Y, Teranishi K, Matsunaga T, Matsushima C, Inagaki M, Suehiro M, Suehiro S, Nishitani M, Kubota H, Iio J, Nishida Y, Katayama T, Takada N, Watanabe K, Yamamoto T, Yasumizu R, Matsuoka K, Ohki K, Kiyokawa N, Maihara T, Usami I. Kobayashi K, et al. Among authors: ono h. J Pediatr Hematol Oncol. 2017 Jul;39(5):e285-e289. doi: 10.1097/MPH.0000000000000809. J Pediatr Hematol Oncol. 2017. PMID: 28267084
BRAF V600 mutations in Langerhans cell histiocytosis with a simple and unique assay.
Tatsuno M, Shioda Y, Iwafuchi H, Yamazaki S, Iijima K, Takahashi C, Ono H, Uchida K, Okamura O, Matubayashi M, Okuyama T, Matsumoto K, Yoshioka T, Nakazawa A. Tatsuno M, et al. Among authors: ono h. Diagn Pathol. 2016 Apr 19;11:39. doi: 10.1186/s13000-016-0489-z. Diagn Pathol. 2016. PMID: 27094161 Free PMC article.
Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors.
Nitani C, Hara J, Kawamoto H, Taguchi T, Kimura T, Yoshimura K, Hamada A, Kitano S, Hattori N, Ushijima T, Ono H, Nakamoto M, Higuchi T, Sato A. Nitani C, et al. Among authors: ono h. Cancer Chemother Pharmacol. 2021 Jul;88(1):99-107. doi: 10.1007/s00280-021-04271-9. Epub 2021 Apr 7. Cancer Chemother Pharmacol. 2021. PMID: 33829292 Clinical Trial.
Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial.
Yagisawa M, Taniguchi H, Satoh T, Kadowaki S, Sunakawa Y, Nishina T, Komatsu Y, Esaki T, Sakai D, Doi A, Kajiwara T, Ono H, Asano M, Hirano N, Odegaard J, Fujii S, Nomura S, Bando H, Sato A, Yoshino T, Nakamura Y. Yagisawa M, et al. Among authors: ono h. J Clin Oncol. 2024 Nov 10;42(32):3817-3825. doi: 10.1200/JCO.23.02626. Epub 2024 Aug 1. J Clin Oncol. 2024. PMID: 39088783 Free PMC article. Clinical Trial.
The real-world impact of biologics for NMOSD: A retrospective single-center study compared with natural course and conventional treatments in Japanese.
Yamazaki N, Misu T, Matsumoto Y, Takai Y, Namatame C, Ono H, Kaneko K, Nishiyama S, Kuroda H, Takahashi T, Nakashima I, Fujihara K, Aoki M. Yamazaki N, et al. Among authors: ono h. Mult Scler Relat Disord. 2024 Nov 16;92:106176. doi: 10.1016/j.msard.2024.106176. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 39579645
[No title available]
Ono H. Ono H. Nihon Yakurigaku Zasshi. 2024;159(6):349-350. doi: 10.1254/fpj.24067. Nihon Yakurigaku Zasshi. 2024. PMID: 39496403 Japanese. No abstract available.
2,678 results